CD274 and neoplasm: Interestingly, while the anti-PD-L1/docetaxel combination was unable to further reduce tumor growth, the anti-PD-L1/TH1902 combination showed significant and greater tumor growth reduction at day 14 post-treatment when compared to that obtained with TH1902 alone.